HK1160927A1 - Urinary biomarkers for predicting long-term dialysis - Google Patents

Urinary biomarkers for predicting long-term dialysis

Info

Publication number
HK1160927A1
HK1160927A1 HK12101200.0A HK12101200A HK1160927A1 HK 1160927 A1 HK1160927 A1 HK 1160927A1 HK 12101200 A HK12101200 A HK 12101200A HK 1160927 A1 HK1160927 A1 HK 1160927A1
Authority
HK
Hong Kong
Prior art keywords
term dialysis
predicting long
urinary biomarkers
biomarkers
urinary
Prior art date
Application number
HK12101200.0A
Other languages
English (en)
Chinese (zh)
Inventor
．星格巴特爾
．科勒姆
Original Assignee
匹茲堡大學高等教育聯邦體系
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 匹茲堡大學高等教育聯邦體系 filed Critical 匹茲堡大學高等教育聯邦體系
Publication of HK1160927A1 publication Critical patent/HK1160927A1/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/38—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence, e.g. gluco- or galactomannans, Konjac gum, Locust bean gum or Guar gum
    • G01N2400/40—Glycosaminoglycans, i.e. GAG or mucopolysaccharides, e.g. chondroitin sulfate, dermatan sulfate, hyaluronic acid, heparin, heparan sulfate, and related sulfated polysaccharides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
HK12101200.0A 2008-09-26 2012-02-08 Urinary biomarkers for predicting long-term dialysis HK1160927A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10058808P 2008-09-26 2008-09-26
US12/565,483 US8501489B2 (en) 2008-09-26 2009-09-23 Urinary biomarkers to predict long-term dialysis
PCT/US2009/005296 WO2010036342A2 (en) 2008-09-26 2009-09-24 Urinary biomarkers for predicting long-term dialysis

Publications (1)

Publication Number Publication Date
HK1160927A1 true HK1160927A1 (en) 2012-08-17

Family

ID=42057868

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12101200.0A HK1160927A1 (en) 2008-09-26 2012-02-08 Urinary biomarkers for predicting long-term dialysis

Country Status (12)

Country Link
US (4) US8501489B2 (ja)
EP (1) EP2344882B1 (ja)
JP (1) JP5479480B2 (ja)
KR (1) KR101680392B1 (ja)
CN (1) CN102216776B (ja)
AU (1) AU2009297098C1 (ja)
BR (1) BRPI0919296A2 (ja)
CA (1) CA2737779C (ja)
HK (1) HK1160927A1 (ja)
MX (1) MX2011003174A (ja)
NZ (1) NZ592473A (ja)
WO (1) WO2010036342A2 (ja)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2735587A1 (en) * 2008-08-28 2010-03-04 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2010025434A1 (en) * 2008-08-29 2010-03-04 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US8501489B2 (en) 2008-09-26 2013-08-06 University of Pittsburgh—of the Commonwealth System of Higher Education Urinary biomarkers to predict long-term dialysis
JP2012506537A (ja) * 2008-10-21 2012-03-15 アスチュート メディカル，インコーポレイテッド 腎損傷および腎不全の診断および予後のための方法および組成物
US20110207161A1 (en) * 2008-10-21 2011-08-25 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US8993250B2 (en) 2008-11-10 2015-03-31 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
MX2011005379A (es) * 2008-11-22 2011-06-09 Astute Medical Inc Metodos y composiciones para diagnosis y prognosis de lesion renal y falla renal.
US9229010B2 (en) 2009-02-06 2016-01-05 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2011017654A1 (en) 2009-08-07 2011-02-10 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
DE102009010563A1 (de) 2009-02-16 2010-08-26 Matthias W. Engel Vorrichtung zum Nachweis von Analyten in Körperflüssigkeiten
EA201290192A1 (ru) 2009-11-07 2013-02-28 Астьют Медикал, Инк. Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности
ES2592386T3 (es) 2009-12-20 2016-11-29 Astute Medical, Inc. Métodos y composiciones para el diagnóstico y pronóstico de lesión renal e insuficiencia renal
US20170074868A1 (en) * 2009-12-20 2017-03-16 Astute Medical, Inc. Methods and compositions for the evaluation of renal injury using hyaluronic acid
MX341191B (es) 2010-02-05 2016-08-10 Astute Medical Inc Metodos y composiciones para diagnostico y prognosis de lesion renal y falla renal.
KR20140051754A (ko) 2010-02-26 2014-05-02 아스튜트 메디컬 인코포레이티드 신장 손상 및 신부전의 진단 및 예후를 위한 방법 및 조성물
EP3339860A1 (en) 2010-06-23 2018-06-27 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP2585825B1 (en) 2010-06-23 2018-01-10 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
ES2619617T3 (es) * 2010-09-24 2017-06-26 Astute Medical, Inc. Procedimientos para la evaluación de una lesión renal utilizando ácido hialurónico
US10557856B2 (en) * 2010-09-24 2020-02-11 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Biomarkers of renal injury
US8486717B2 (en) 2011-01-18 2013-07-16 Symbolics, Llc Lateral flow assays using two dimensional features
EP2668497B1 (en) 2011-01-26 2020-03-25 University of Pittsburgh - Of the Commonwealth System of Higher Education Urine biomarkers for prediction of recovery after acute kidney injury : proteomics
ES2933570T3 (es) 2011-12-08 2023-02-10 Astute Medical Inc Métodos y composiciones para el diagnóstico y el pronóstico de una lesión renal y de una insuficiencia renal
US9874556B2 (en) 2012-07-18 2018-01-23 Symbolics, Llc Lateral flow assays using two dimensional features
WO2014028339A1 (en) 2012-08-11 2014-02-20 Astute Medical, Inc. Evaluating renal injury using hyaluronic acid
ES2681955T3 (es) 2013-01-17 2018-09-17 Astute Medical, Inc. Métodos y composiciones para el diagnóstico y pronóstico de lesión renal e insuficiencia renal
US9599615B2 (en) 2013-03-13 2017-03-21 Symbolics, Llc Lateral flow assays using two dimensional test and control signal readout patterns
US10493232B2 (en) 2015-07-20 2019-12-03 Strataca Systems Limited Ureteral catheters, bladder catheters, systems, kits and methods for inducing negative pressure to increase renal function
MA42500A (fr) 2015-07-20 2018-05-30 Strataca Systems Llc Dispositif de sonde et procédé d'induction d'une pression négative dans la vessie d'un patient
US10512713B2 (en) 2015-07-20 2019-12-24 Strataca Systems Limited Method of removing excess fluid from a patient with hemodilution
US10765834B2 (en) 2015-07-20 2020-09-08 Strataca Systems Limited Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion
US11541205B2 (en) 2015-07-20 2023-01-03 Roivios Limited Coated urinary catheter or ureteral stent and method
US10918827B2 (en) 2015-07-20 2021-02-16 Strataca Systems Limited Catheter device and method for inducing negative pressure in a patient's bladder
US11040180B2 (en) 2015-07-20 2021-06-22 Strataca Systems Limited Systems, kits and methods for inducing negative pressure to increase renal function
US11229771B2 (en) 2015-07-20 2022-01-25 Roivios Limited Percutaneous ureteral catheter
US11040172B2 (en) 2015-07-20 2021-06-22 Strataca Systems Limited Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion
US12064567B2 (en) 2015-07-20 2024-08-20 Roivios Limited Percutaneous urinary catheter
US10926062B2 (en) 2015-07-20 2021-02-23 Strataca Systems Limited Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion
JP2019523889A (ja) 2016-06-06 2019-08-29 アスチュート メディカル，インコーポレイテッド インスリン様増殖因子結合タンパク質７およびメタロプロテアーゼ２の組織阻害剤を使用する急性腎臓傷害の管理
EP3630691A1 (en) 2017-06-02 2020-04-08 Guardian Glass, LLC Glass article containing a coating with an interpenetrating polymer network
EP3665705A1 (en) 2017-08-08 2020-06-17 Fresenius Medical Care Holdings, Inc. Systems and methods for treating and estimating progression of chronic kidney disease
EP3672677A1 (en) 2017-08-25 2020-07-01 Strataca Systems Limited Indwelling pump for facilitating removal of urine from the urinary tract
KR102012899B1 (ko) * 2017-09-27 2019-08-21 전남대학교산학협력단 급성신장손상으로 인한 신장대체요법 중단시기 결정방법 및 중단시기결정용 진단키트
KR102077987B1 (ko) * 2018-12-19 2020-02-17 주식회사 헬릭스미스 신장 질환 진단용 바이오 마커
KR102319190B1 (ko) * 2018-12-19 2021-10-29 서울대학교병원 신장 질환 진단용 바이오 마커
CN112881562A (zh) * 2021-02-07 2021-06-01 苏州大学附属第一医院 葡糖醛酸作为慢性肾脏病早期诊断标志物的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000504114A (ja) * 1996-02-01 2000-04-04 ユニバーシティー オブ マイアミ 膀胱癌の検出及び評価方法
US6350571B1 (en) * 1996-02-01 2002-02-26 Vinata B. Lokeshwar Methods for detection and evaluation of bladder cancer
JP3846973B2 (ja) * 1997-06-06 2006-11-15 生化学工業株式会社 慢性炎症の判定方法及びキット
US7138230B2 (en) * 2002-12-06 2006-11-21 Renovar, Inc. Systems and methods for characterizing kidney diseases
EP1654659A4 (en) 2003-08-05 2007-05-09 Sepaton Inc EMULATED STORAGE SYSTEM
CN1869702A (zh) * 2005-05-24 2006-11-29 穆海东 肝炎与肝硬化的集成检测反应板和蛋白芯片试剂盒
ES2430290T3 (es) 2007-03-06 2013-11-19 F. Hoffmann-La Roche Ag Utilización de péptidos de tipo PNC para predecir la necesidad de diálisis
US8501489B2 (en) 2008-09-26 2013-08-06 University of Pittsburgh—of the Commonwealth System of Higher Education Urinary biomarkers to predict long-term dialysis

Also Published As

Publication number Publication date
CN102216776A (zh) 2011-10-12
WO2010036342A9 (en) 2010-07-08
KR101680392B1 (ko) 2016-11-28
US20130299427A1 (en) 2013-11-14
EP2344882B1 (en) 2017-05-10
AU2009297098A1 (en) 2010-04-01
BRPI0919296A2 (pt) 2015-12-15
AU2009297098B2 (en) 2015-01-22
EP2344882A2 (en) 2011-07-20
WO2010036342A2 (en) 2010-04-01
NZ592473A (en) 2012-11-30
US9057722B2 (en) 2015-06-16
US20140329256A1 (en) 2014-11-06
US20150330975A1 (en) 2015-11-19
US8815602B2 (en) 2014-08-26
CA2737779C (en) 2018-05-22
CN102216776B (zh) 2015-01-28
US9389222B2 (en) 2016-07-12
KR20110097760A (ko) 2011-08-31
US20100081148A1 (en) 2010-04-01
EP2344882A4 (en) 2013-01-23
US8501489B2 (en) 2013-08-06
JP2012503772A (ja) 2012-02-09
MX2011003174A (es) 2011-09-15
CA2737779A1 (en) 2010-04-01
AU2009297098C1 (en) 2015-07-30
JP5479480B2 (ja) 2014-04-23

Similar Documents

Publication Publication Date Title
HK1160927A1 (en) Urinary biomarkers for predicting long-term dialysis
EP2373999A4 (en) NEW BIOMARKERS
GB2474618B (en) Predictive biomarkers
EP2265642A4 (en) BIOMARKERS
IL216720A (en) Biological markers for assessing kidney disease
EP2089722A4 (en) BIOMARKERS
EP2245464A4 (en) P53 BIOMARKERS
EP2282211A4 (en) AUTOMATIC ANALYZER
ZA200907027B (en) Biomarkers for multiple sclerosis
EP2263086A4 (en) BIOMARKERS
GB0810709D0 (en) Biomarkers for lupus
GB0618127D0 (en) Biomarker
EP2275801A4 (en) AUTOMATIC ANALYZER
ZA201105184B (en) Biomarker
GB0709803D0 (en) Predictive method
GB0818660D0 (en) Biomarkers
GB0807214D0 (en) Biomarkers
HK1171811A1 (zh) 用於癌症診斷的尿生物標誌物
EP2265641A4 (en) BIOMARKERS
EP2347039A4 (en) BIOMARKER FOR DENGUE
GB0722068D0 (en) Predictive test
GB0612669D0 (en) Biomarkers for preeclampsia
GB0821912D0 (en) Biomarkers
GB0818658D0 (en) Biomarkers
EP2343554A4 (en) BIOMARKER FOR DISORDERS OF A MICRODOMAINE

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20210924